Viewing Study NCT01004432

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-29 @ 2:16 AM
Study NCT ID: NCT01004432
Status: COMPLETED
Last Update Posted: 2015-04-30
First Post: 2009-10-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Sponsor: Janssen Biotech, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis View
None Arthritis, Rheumatoid View
None Autoimmune Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None humira, remicade View
None rheumatoid arthritis View
None enbrel failure View
None humira failure View
None arthritis View
None enbrel View